ConductScience.org, home

Paper39398174

Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs.

Hayat K and 3 others. ACS Omega, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs. Papers, record 39398174. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39398174

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Symmetrical Phosphinic Acids: Synthesis and Esterification Optimization toward Potential HIV Prodrugs.
PubMed
Journal
ACS Omega
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.54, provisional
iCite
Revised in PubMed
2024-10-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131488882Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression.Cell Res2019https://conductscience.org/library/papers/31488882PubMed
21637805Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.Biochemistry1992https://conductscience.org/library/papers/1637805PubMed
315379718Lipid, sugar and liposaccharide based delivery systems 2.Curr Med Chem2004https://conductscience.org/library/papers/15379718PubMed
438007463Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening.BMC Chem2023https://conductscience.org/library/papers/38007463PubMed
54159616Treatment of chronic portal-systemic encephalopathy with lactulose.Lancet1966https://conductscience.org/library/papers/4159616PubMed
635340621An ethnopharmacological review on the therapeutical properties of flavonoids and their mechanisms of actions: A comprehensive review based on up to date knowledge.Toxicol Rep2022https://conductscience.org/library/papers/35340621PubMed
72268900Hypoglycemic effect of intestinally administered monosaccharide-modified insulin derivatives in rats.Chem Pharm Bull (Tokyo)1990https://conductscience.org/library/papers/2268900PubMed
816983718Carbohydrates as scaffolds in drug discovery.ChemMedChem2006https://conductscience.org/library/papers/16983718PubMed
911472244Lipid, sugar and liposaccharide based delivery systems.Curr Med Chem2001https://conductscience.org/library/papers/11472244PubMed
109406592Intensely cytotoxic anthracycline prodrugs: glucuronides.J Med Chem1997https://conductscience.org/library/papers/9406592PubMed
1135785277Unprecedented Convergent Synthesis of Sugar-Functionalization of Phosphinic Acids under Metal-Free Conditions.ACS Omega2022https://conductscience.org/library/papers/35785277PubMed
128259000Inhibitors of aspartyl proteinases.Med Res Rev1993https://conductscience.org/library/papers/8259000PubMed
1330481556Phosphinic acids: current status and potential for drug discovery.Drug Discov Today2019https://conductscience.org/library/papers/30481556PubMed
1424077675Glucose conjugation for the specific targeting and treatment of cancer.Chem Sci2013https://conductscience.org/library/papers/24077675PubMed
1531900143Synthetic carbohydrate-based vaccines: challenges and opportunities.J Biomed Sci2020https://conductscience.org/library/papers/31900143PubMed
1629946963Empagliflozin: A Review in Type 2 Diabetes.Drugs2018https://conductscience.org/library/papers/29946963PubMed
1731236801Dapagliflozin: A Review in Type 2 Diabetes.Drugs2019https://conductscience.org/library/papers/31236801PubMed
1823434657Flavonoids as antioxidants and developmental regulators: relative significance in plants and humans.Int J Mol Sci2013https://conductscience.org/library/papers/23434657PubMed
198347601Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysis.Biochemistry1993https://conductscience.org/library/papers/8347601PubMed
2034171659Application of carbohydrates in approved small molecule drugs: A review.Eur J Med Chem2021https://conductscience.org/library/papers/34171659PubMed

See all 34 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
41476560Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies.ACS Omega2025https://conductscience.org/library/papers/41476560

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39398174

GET https://conductscience.org/api/papers/v1/39398174/references?page=2